+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Disposable Syringes Market Size, Share & Industry Trends Analysis Report By Application (Therapeutic Injections, and Immunization Injections), By Product, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 84 Pages
  • June 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5851927
The Europe Disposable Syringes Market should witness market growth of 5.9% CAGR during the forecast period (2023-2030).

Disposable syringes are quickly replacing traditional glass syringes because they are inexpensive, ready to use, and readily available in a sterilized condition. The usage of these syringes has increased dramatically as the scourge of AIDS has virtually abolished the practice of using previously used needles. The majority of disposable syringes are injection-molded polypropylene. Syringes comprise two or three parts and come in sizes of 1 ml, 2 ml, 5 ml, and 10 ml. The quantity and size of injection molding machines required are determined by the syringe design, the number of mold cavities, and the annual output.

The manufacturers are investing in various nations by introducing new products. One of the main drivers of the target market's growth is the existence of significant industry players, modern healthcare infrastructure, and government initiatives. Organizations are improving the quality and services related to disposable syringes while lowering the cost of their products. These operational strategies help organizations save money by lowering third-party expenses. These characteristics are expected to create lucrative potential for market expansion.

In Europe, diabetes is growing more prevalent among people of all ages due to rising rates of overweight and obesity, a bad diet, and insufficient exercise. Sixty million people in the European region have diabetes, representing 10.3% of men and 9.6% of women who are 25 years of age or older. Furthermore, diabetes has been detected in 15.3% of Germans, according to the International Diabetes Federation (IDF). The requirement for preventive treatment comes from the rising prevalence of diabetes. Thus, the demand across the region is predicted to grow as a result.

The Germany market dominated the Europe Disposable Syringes Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,416.6 Million by 2030. The UK market is exhibiting a CAGR of 5% during (2023-2030). Additionally, The France market would display a CAGR of 6.7% during (2023-2030).

Based on Application, the market is segmented into Therapeutic Injections, and Immunization Injections. Based on Product, the market is segmented into Safety Syringes (Retractable, and Non-retractable), and Conventional Syringes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Fresenius SE & Co. KGaA, Terumo Corporation, Novo Nordisk A/S, Baxter International, Inc., B. Braun Melsungen AG, Flextronics International, Ltd., Nipro Corporation, and UltiMed, Inc.

Scope of the Study

By Application

  • Therapeutic Injections
  • Immunization Injections

By Product

  • Safety Syringes
    • Retractable
    • Non-retractable
  • Conventional Syringes

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Becton, Dickinson and Company
  • Medtronic PLC
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • Novo Nordisk A/S
  • Baxter International, Inc.
  • B.Braun Melsungen AG
  • Flextronics International, Ltd.
  • Nipro Corporation
  • UltiMed, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Disposable Syringes Market, by Application
1.4.2 Europe Disposable Syringes Market, by Product
1.4.3 Europe Disposable Syringes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Disposable Syringes Market by Application
3.1 Europe Therapeutic Injections Market by Country
3.2 Europe Immunization Injections Market by Country
Chapter 4. Europe Disposable Syringes Market by Product
4.1 Europe Safety Syringes Market by Country
4.2 Europe Disposable Syringes Market by Safety Syringes Type
4.2.1 Europe Retractable Market by Country
4.2.2 Europe Non-retractable Market by Country
4.3 Europe Conventional Syringes Market by Country
Chapter 5. Europe Disposable Syringes Market by Country
5.1 Germany Disposable Syringes Market
5.1.1 Germany Disposable Syringes Market by Application
5.1.2 Germany Disposable Syringes Market by Product
5.1.2.1 Germany Disposable Syringes Market by Safety Syringes Type
5.2 UK Disposable Syringes Market
5.2.1 UK Disposable Syringes Market by Application
5.2.2 UK Disposable Syringes Market by Product
5.2.2.1 UK Disposable Syringes Market by Safety Syringes Type
5.3 France Disposable Syringes Market
5.3.1 France Disposable Syringes Market by Application
5.3.2 France Disposable Syringes Market by Product
5.3.2.1 France Disposable Syringes Market by Safety Syringes Type
5.4 Russia Disposable Syringes Market
5.4.1 Russia Disposable Syringes Market by Application
5.4.2 Russia Disposable Syringes Market by Product
5.4.2.1 Russia Disposable Syringes Market by Safety Syringes Type
5.5 Spain Disposable Syringes Market
5.5.1 Spain Disposable Syringes Market by Application
5.5.2 Spain Disposable Syringes Market by Product
5.5.2.1 Spain Disposable Syringes Market by Safety Syringes Type
5.6 Italy Disposable Syringes Market
5.6.1 Italy Disposable Syringes Market by Application
5.6.2 Italy Disposable Syringes Market by Product
5.6.2.1 Italy Disposable Syringes Market by Safety Syringes Type
5.7 Rest of Europe Disposable Syringes Market
5.7.1 Rest of Europe Disposable Syringes Market by Application
5.7.2 Rest of Europe Disposable Syringes Market by Product
5.7.2.1 Rest of Europe Disposable Syringes Market by Safety Syringes Type
Chapter 6. Company Profiles
6.1 Becton, Dickinson and Company
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.1.6 SWOT Analysis
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Fresenius SE & Co. KGaA
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Terumo Corporation
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Novo Nordisk A/S
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental & Regional Analysis
6.5.4 Research & Development Expenses
6.6 Baxter International, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 B. Braun Melsungen AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Flextronics International, Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional and Segmental Analysis
6.9 Nipro Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.10. UltiMed, Inc.
6.10.1 Company Overview

Companies Mentioned

  • Becton, Dickinson and Company
  • Medtronic PLC
  • Fresenius SE & Co. KGaA
  • Terumo Corporation
  • Novo Nordisk A/S
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Flextronics International, Ltd.
  • Nipro Corporation
  • UltiMed, Inc.

Methodology

Loading
LOADING...